| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
20,430,000 |
| Market
Cap: |
1.37(B) |
| Last
Volume: |
2,387,520 |
Avg
Vol: |
2,380,888 |
| 52
Week Range: |
$38.04 - $69.69 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
254,921 |
421,551 |
1,262,027 |
1,480,093 |
| Total Sell Value |
$16,747,919 |
$26,516,522 |
$74,515,877 |
$82,888,946 |
| Total People Sold |
8 |
9 |
12 |
12 |
| Total Sell Transactions |
23 |
40 |
87 |
90 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kjaer Peter |
Director |
– • – |
2003-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
124 |
11,562 |
|
- |
|
| Mangano Ross J |
Director |
– • • |
2003-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
124 |
29,006 |
|
- |
|
| Sullivan Louis |
Director |
– • – |
2003-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
113 |
14,526 |
|
- |
|
| Holubow Fred |
Director |
– • – |
2003-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
113 |
57,367 |
|
- |
|
| Kjaer Peter |
Director |
– • – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
345 |
11,438 |
|
- |
|
| Ho Angela |
Director |
– • – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
172 |
72,032 |
|
- |
|
| Holubow Fred |
Director |
– • – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
690 |
57,254 |
|
- |
|
| Morgenstern Victor A |
Director |
– • – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
345 |
356,153 |
|
- |
|
| Mangano Ross J |
Director |
– • • |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
345 |
28,882 |
|
- |
|
| Holubow Fred |
Director |
– • – |
2003-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
186 |
56,564 |
|
- |
|
| Perceptive Advisors Llc |
10% Owner |
– – • |
2003-08-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,392,400 |
|
- |
|
| Perceptive Advisors Llc |
10% Owner |
– – • |
2003-08-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
225,000 |
|
- |
|
| Morgenstern Victor A |
Director |
– • – |
2003-08-04 |
4 |
B |
$2.15 |
$301,000 |
I/I |
140,000 |
270,000 |
2.1 |
- |
|
| Morgenstern Victor A |
Director |
– • – |
2003-08-04 |
4 |
B |
$2.15 |
$328,950 |
D/D |
153,000 |
355,808 |
2.39 |
- |
|
| Simes Stephen M |
officerTitle |
• • – |
2003-08-04 |
4 |
B |
$2.15 |
$2,150 |
I/I |
1,000 |
63,500 |
2.58 |
- |
|
| Lehman Leah M |
officerTitle |
• – – |
2003-08-04 |
4 |
B |
$2.15 |
$2,150 |
D/D |
1,000 |
159,777 |
2.66 |
- |
|
| Donenberg Philip B |
CFO, Treasurer and Secretary |
• – – |
2003-08-04 |
4 |
B |
$2.15 |
$2,150 |
D/D |
1,000 |
13,974 |
2.66 |
- |
|
| Holubow Fred |
Director |
– • – |
2003-08-04 |
4 |
B |
$2.15 |
$322,500 |
I/I |
150,000 |
210,000 |
2.1 |
- |
|
| Mangano Ross J |
Director |
– • • |
2003-08-04 |
4 |
B |
$2.15 |
$629,999 |
I/I |
293,023 |
1,314,027 |
2.25 |
- |
|
| Sullivan Louis |
Director |
– • – |
2003-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
186 |
14,413 |
|
- |
|
| Rosenow Edward C III |
Director |
– • – |
2003-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
186 |
12,041 |
|
- |
|
| Kjaer Peter |
Director |
– • – |
2003-07-17 |
4 |
A |
$0.00 |
$0 |
D/D |
186 |
11,093 |
|
- |
|
722 Records found
|
|
Page 29 of 29 |
|
|
0.14 (0.21%) 
